References
- Hardiman O, Clalabi A, Brayne C, Beghi E, vanden Berg L, Chio A, Martin S, et al. The changing picture of amyotrophic lateral sclerosis: lessons from European registries. J Neurol Neurosurg Psychiatry. 2017;0:1–7.
- Cronin S, Hardiman O, Traynor BJ. Ethnic variation in the incidence of ALS: a systematic review. Neurology. 2007;68:1002–7.
- Gundogdu B, Al-Lahham T, Kadlubar F, Spencer H, Rudnicki SA. Racial differences in motor neuron disease. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:114–8.
- Zaldivar T, Gutierrez J, Lara G, Carbonara M, Logroscino G, Hardiman O. Reduced frequency of ALS in an ethnically mixed population: a population-based mortality study. Neurology. 2009; 72:1640–5.
- Wagner L, Archer NP, Williamson D, et al. Prevalence of amyotrophic lateral sclerosis in Texas, 1998-2003. Tex Med. 2012; 108:e1.
- Turabelidze G, Zhu B, Schootman M, Malone J, Horowitz S, Weidinger J, et al. An epidemiological investigation of amyotrophic lateral sclerosis in Jefferson County, Missouri, 1998-2002. Neurotoxicology. 2008; 29:81–6.
- Haper C, Sorenson E, Mandrekar J. Epidemiology of amyotrophic lateral sclerosis in Minnesota: a year-long population based study. Amyotroph Lateral Scler Frontotemporal Degener. 2015; 16:520–3.
- Mehta P, Kaye W, Bryan L, et al. Prevalence of amyotrophic lateral Sclerosis – United States, 2012-2013. MMWR Surveill Summ. 2016;65:1–12.
- Antao VC, Horton DK. The National Amyotrophic Lateral Sclerosis (ALS) Registry. J Environ Health. 2012;75:28–30.
- Mehta P, Antao V, Kaye W, et al. Prevalence of amyotrophic lateral sclerosis—United States, 2010–2011. MMWR. 2014;63:1–13.
- Wagner L, Rechtman L, Jordan H, Ritsick M, Sanchez M, Sorenson E, et al. State and metropolitan area-based amyotrophic lateral sclerosis (ALS) surveillance. Amyotroph Lateral Scler Frontotemporal Degener. 2015;17:128–34.
- US Public Health Service. ALS Registry Act. Washington, DC: 110th Congress. Public Law 2008; 122 Stat 4047:110–373. Available at http://wwwn.cdc.gov/als/Download/ALS%20Registry%20Act%20(Public%20Law%20110-373).pdf.
- Kaye WE, Sanchez M, Wu J. Feasibility of creating a national ALS registry using administrative data in the United States. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:433–9.
- Allen KD, Kasarskis EJ, Bedlack RS, et al. The National Registry of Veterans with Amyotrophic Lateral Sclerosis. Neuroepidemiology. 2008;30:180–90. http://dx.doi.org/10.1159/000126910
- SAS Institute Inc. 2011. Base SAS© 9.3 procedures guide. Cary, NC: SAS Institute Inc.
- Strickland D, Bertoni JM. Parkinson's prevalence estimated by a state registry. Mov Disord. 2004;19:318–23.
- South Carolina Alzheimer’s Disease RegistryAnnual Report 2005. Columbia, SC: Arnold School of Public Health, University of South Carolina. Available at: http://www.sph.sc.edu/osa/documents/ANNUALREPORT05.pdf. Accessed on July 27, 2006.
- Lillquist PP. Challenges in surveillance of dementias in New York State. Prev Chronic Dis. 2004;1:A08.
- Data Brief: The Argeo Paul Cellucci Amyotrophic Lateral Sclerosis (ALS) Registry of Massachusetts. Massachusetts Department of Public Health May 2016. http://www.mass.gov/eohhs/docs/dph/environmental/als/als-registry-data-brief-050916.pdf
- Rooney J, Brayne C, Tobin K, Logroscino G, Glymour M, Hardiman O. Benefits, pitfalls, and future design of population-based registers in neurodegenerative disease. Neurology. 2017; 88:2321–9.
- Logroscino G, Traynor B, Hardiman O, Chio A, Mitchell D, Swingler R, EURALS, et al. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Psychiatry. 2010;81:385–90.
- Humes KR, Jones NA, Ramirez RR. 2010 Census Briefs: Overview of Race and Hispanic Origin: 2010. Washington, DC: U.S. Census Bureau; 2011. http://www.census.gov/prod/cen2010/briefs/c2010br-02.pdf
- Social Security, Program Operations Manual (POMS): DI 11036.001 Ammyotrophic Lateral Sclerosisi (ALS) – Medicare Waiting Period Waived – Field Office (FO), https://secure.ssa.gov/poms.nsf/lnx/0411036001 accessed December 29, 2016.
- Pupillo E, Bianchi E, Poloni M, Beghi E. for the SLALOM Group. Is firstly diagnosed ALS really ALS? Results of a population-based study with long-term followup. Amyotroph Lateral Scler Frontotemporal Degener. 2016; 28:1–6.
- Guidry JJ, Torrence W, Herbelin S. Closing the divide: diverse populations and cancer survivorship. Cancer. 2005;104:2577–83.
- Botticello AL, Boninger M, Charlifue S, Chen Y, Fyffe D, Heinemann A, et al. To what extent do neighborhood differences mediate racial disparities in participation after spinal cord injury? Arch Phys Med Rehabil. 2016;97:1735–44.